These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Longitudinal effect of olanzapine on fasting serum lipids: a randomized, prospective, 4-month study. Kinon BJ; Liu-Seifert H; Ahl J; Ahmed S; Baker RW Ann N Y Acad Sci; 2004 Dec; 1032():295-6. PubMed ID: 15677433 [TBL] [Abstract][Full Text] [Related]
8. The incidence of hyperglycemia in patients treated with olanzapine. Misawa F; Miyaji S; Fuji Y; Miyata R; Obi K; Koshiishi F; Shimada H; Fukuda M; Koizumi T J Clin Psychiatry; 2004 Mar; 65(3):443-4. PubMed ID: 15096088 [No Abstract] [Full Text] [Related]
9. Olanzapine in schizophrenia and affective disorders. Undurraga J; Vieta E; Tohen M; Colom F Drug Saf; 2012 Dec; 35(12):1185-6; author reply 1186. PubMed ID: 23137154 [No Abstract] [Full Text] [Related]
10. Diabetes and psychosis: olanzapine may not be the culprit. Levy P Hong Kong Med J; 2007 Aug; 13(4):335. PubMed ID: 17664543 [No Abstract] [Full Text] [Related]
11. Skin hyperpigmentation induced by olanzapine, a novel antipsychotic agent. Jhirwal OP; Parsad D; Basu D Int J Dermatol; 2004 Oct; 43(10):778-9. PubMed ID: 15485541 [No Abstract] [Full Text] [Related]
13. Late-onset cholestatic hepatitis induced by olanzapine in a patient with schizophrenia. Hung CC; Wei IH; Huang CC Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1574-5. PubMed ID: 19766687 [No Abstract] [Full Text] [Related]
14. Neutropenia associated with quetiapine, olanzapine, and aripiprazole. Lander M; Bastiampillai T Aust N Z J Psychiatry; 2011 Jan; 45(1):89. PubMed ID: 21058927 [No Abstract] [Full Text] [Related]
15. Blonanserin improved dystonia induced by risperidone or olanzapine in two patients with schizophrenia. Takaki M; Mizuki Y; Miki T J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E14. PubMed ID: 24763772 [No Abstract] [Full Text] [Related]
16. Clinical consequences of switching antipsychotic drugs in outpatients with schizophrenia: 36-month results from the European Schizophrenia Outpatient Health Outcomes study. Novick D; Haro JM; Suarez D; Marques-Teixeira J; Naber D Int Clin Psychopharmacol; 2008 Jul; 23(4):203-8. PubMed ID: 18545058 [TBL] [Abstract][Full Text] [Related]
17. Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies. Zipris P; Melamed Y; Weizman A; Bleich A Isr J Psychiatry Relat Sci; 2007; 44(1):54-6. PubMed ID: 17665812 [TBL] [Abstract][Full Text] [Related]
18. Prolongation of clozapine-induced neutropenia with olanzapine. Jagadheesan K; Mehrtens J Aust N Z J Psychiatry; 2007 Feb; 41(2):192. PubMed ID: 17464699 [No Abstract] [Full Text] [Related]
19. [Olanzapine-associated neuroleptic malignant syndrome. A case report and favorable response to risperidone]. López-Torres E; Cobo I; Lucena MI Actas Esp Psiquiatr; 2007; 35(2):145-6. PubMed ID: 17401786 [No Abstract] [Full Text] [Related]
20. Safety of olanzapine use in adolescents. Schulz C; Haight RJ Expert Opin Drug Saf; 2013 Sep; 12(5):777-82. PubMed ID: 23876012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]